Landscapes / Companies

Vir Biotechnology, Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
1 in Phase 2
Next date
Elebsiran, Phase 3 trial completes
Drugs
4
in active trials · 10 in all
Trials
6 active
21 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
Small interfering RNA
Phase 3 Dec 2026Phase 3 trial completes
Artificial immunoglobulin
Phase 3 Dec 2026Phase 3 trial completes
—
Phase 1/2 Apr 2028Phase 1/2 trial completes
—
Phase 1 Aug 2029Phase 1 trial completes

About

No active trial
6 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Vir Biotechnology, Inc.

Following is part of Solo: you see every change to Vir Biotechnology, Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in